Get Real Time Here
| Open3.900 | Close3.660 |
| Vol / Avg.87.133K / 142.551K | Mkt Cap90.606M |
| Day Range3.650 - 3.900 | 52 Wk Range2.190 - 5.790 |
Abeona Therapeutics Stock (NASDAQ:ABEO), Quotes and News Summary
Abeona Therapeutics Stock (NASDAQ: ABEO) stock price, news, charts, stock research, profile.
| Open3.900 | Close3.660 |
| Vol / Avg.87.133K / 142.551K | Mkt Cap90.606M |
| Day Range3.650 - 3.900 | 52 Wk Range2.190 - 5.790 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.680 | -0.920 | -0.2400 | ||||
| REV | 3.500M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-24 | Cantor Fitzgerald | Kristen Kluska | Reiterates | OverweightOverweight | Maintains | - | 38.00 |
| 2023-07-13 | Cantor Fitzgerald | Kristen Kluska | Reiterates | OverweightOverweight | Maintains | - | 38.00 |
| 2023-05-24 | Alliance Global Partners | James Molloy | Reiterates | Buy | Maintains | - | 20.00 |
| 2022-11-14 | SVB Leerink | Mani Foroohar | Maintains | Market Perform | Raises | 5.00 | 6.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| ABEO | Abeona Therapeutics | -3.43% | 90.6M |
| IMNM | Immunome | -2.97% | 85.7M |
| CTMX | CytomX Therapeutics | -1.56% | 84.1M |
| BNR | Burning Rock Biotech | 0.99% | 102.7M |
| TTOO | T2 Biosystems | -13.62% | 73.2M |
How do I buy Abeona Therapeutics (ABEO) stock?
You can purchase shares of Abeona Therapeutics (NASDAQ: ABEO) through any online brokerage.
Who are Abeona Therapeutics's (ABEO) competitors?
Other companies in Abeona Therapeutics’s space includes: Immunome (NASDAQ:IMNM), CytomX Therapeutics (NASDAQ:CTMX), Burning Rock Biotech (NASDAQ:BNR), T2 Biosystems (NASDAQ:TTOO) and Armata Pharmaceuticals (AMEX:ARMP).
What is the target price for Abeona Therapeutics (ABEO) stock?
The latest price target for Abeona Therapeutics (NASDAQ: ABEO) was reported by Cantor Fitzgerald on Thursday, August 24, 2023. The analyst firm set a price target for 38.00 expecting ABEO to rise to within 12 months (a possible 938.25% upside). 5 analyst firms have reported ratings in the last year.
Current Stock Price for Abeona Therapeutics (ABEO)?
The stock price for Abeona Therapeutics (NASDAQ: ABEO) is $3.66 last updated September 25, 2023 at 8:00 PM UTC.
Does Abeona Therapeutics (ABEO) pay a dividend?
There is no dividend information for Abeona Therapeutics.
When is Abeona Therapeutics (NASDAQ:ABEO) reporting earnings?
Abeona Therapeutics’s Q3 earnings are confirmed for Monday, November 13, 2023.
Is Abeona Therapeutics (ABEO) going to split?
There is no upcoming split for Abeona Therapeutics.
What sector and industry does Abeona Therapeutics (ABEO) operate in?
Abeona Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Abeona Therapeutics Stock (NASDAQ:ABEO), Quotes and News Summary
Abeona Therapeutics Stock (NASDAQ: ABEO) stock price, news, charts, stock research, profile.
| Open3.900 | Close3.660 |
| Vol / Avg.87.133K / 142.551K | Mkt Cap90.606M |
| Day Range3.650 - 3.900 | 52 Wk Range2.190 - 5.790 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.680 | -0.920 | -0.2400 | ||||
| REV | 3.500M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-24 | Cantor Fitzgerald | Kristen Kluska | Reiterates | OverweightOverweight | Maintains | - | 38.00 |
| 2023-07-13 | Cantor Fitzgerald | Kristen Kluska | Reiterates | OverweightOverweight | Maintains | - | 38.00 |
| 2023-05-24 | Alliance Global Partners | James Molloy | Reiterates | Buy | Maintains | - | 20.00 |
| 2022-11-14 | SVB Leerink | Mani Foroohar | Maintains | Market Perform | Raises | 5.00 | 6.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| ABEO | Abeona Therapeutics | -3.43% | 90.6M |
| IMNM | Immunome | -2.97% | 85.7M |
| CTMX | CytomX Therapeutics | -1.56% | 84.1M |
| BNR | Burning Rock Biotech | 0.99% | 102.7M |
| TTOO | T2 Biosystems | -13.62% | 73.2M |
How do I buy Abeona Therapeutics (ABEO) stock?
You can purchase shares of Abeona Therapeutics (NASDAQ: ABEO) through any online brokerage.
Who are Abeona Therapeutics's (ABEO) competitors?
Other companies in Abeona Therapeutics’s space includes: Immunome (NASDAQ:IMNM), CytomX Therapeutics (NASDAQ:CTMX), Burning Rock Biotech (NASDAQ:BNR), T2 Biosystems (NASDAQ:TTOO) and Armata Pharmaceuticals (AMEX:ARMP).
What is the target price for Abeona Therapeutics (ABEO) stock?
The latest price target for Abeona Therapeutics (NASDAQ: ABEO) was reported by Cantor Fitzgerald on Thursday, August 24, 2023. The analyst firm set a price target for 38.00 expecting ABEO to rise to within 12 months (a possible 938.25% upside). 5 analyst firms have reported ratings in the last year.
Current Stock Price for Abeona Therapeutics (ABEO)?
The stock price for Abeona Therapeutics (NASDAQ: ABEO) is $3.66 last updated September 25, 2023 at 8:00 PM UTC.
Does Abeona Therapeutics (ABEO) pay a dividend?
There is no dividend information for Abeona Therapeutics.
When is Abeona Therapeutics (NASDAQ:ABEO) reporting earnings?
Abeona Therapeutics’s Q3 earnings are confirmed for Monday, November 13, 2023.
Is Abeona Therapeutics (ABEO) going to split?
There is no upcoming split for Abeona Therapeutics.
What sector and industry does Abeona Therapeutics (ABEO) operate in?
Abeona Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Abeona Therapeutics Stock (NASDAQ:ABEO), Quotes and News Summary
Abeona Therapeutics Stock (NASDAQ: ABEO) stock price, news, charts, stock research, profile.
| Open3.900 | Close3.660 |
| Vol / Avg.87.133K / 142.551K | Mkt Cap90.606M |
| Day Range3.650 - 3.900 | 52 Wk Range2.190 - 5.790 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.680 | -0.920 | -0.2400 | ||||
| REV | 3.500M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-24 | Cantor Fitzgerald | Kristen Kluska | Reiterates | OverweightOverweight | Maintains | - | 38.00 |
| 2023-07-13 | Cantor Fitzgerald | Kristen Kluska | Reiterates | OverweightOverweight | Maintains | - | 38.00 |
| 2023-05-24 | Alliance Global Partners | James Molloy | Reiterates | Buy | Maintains | - | 20.00 |
| 2022-11-14 | SVB Leerink | Mani Foroohar | Maintains | Market Perform | Raises | 5.00 | 6.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| ABEO | Abeona Therapeutics | -3.43% | 90.6M |
| IMNM | Immunome | -2.97% | 85.7M |
| CTMX | CytomX Therapeutics | -1.56% | 84.1M |
| BNR | Burning Rock Biotech | 0.99% | 102.7M |
| TTOO | T2 Biosystems | -13.62% | 73.2M |
How do I buy Abeona Therapeutics (ABEO) stock?
You can purchase shares of Abeona Therapeutics (NASDAQ: ABEO) through any online brokerage.
Who are Abeona Therapeutics's (ABEO) competitors?
Other companies in Abeona Therapeutics’s space includes: Immunome (NASDAQ:IMNM), CytomX Therapeutics (NASDAQ:CTMX), Burning Rock Biotech (NASDAQ:BNR), T2 Biosystems (NASDAQ:TTOO) and Armata Pharmaceuticals (AMEX:ARMP).
What is the target price for Abeona Therapeutics (ABEO) stock?
The latest price target for Abeona Therapeutics (NASDAQ: ABEO) was reported by Cantor Fitzgerald on Thursday, August 24, 2023. The analyst firm set a price target for 38.00 expecting ABEO to rise to within 12 months (a possible 938.25% upside). 5 analyst firms have reported ratings in the last year.
Current Stock Price for Abeona Therapeutics (ABEO)?
The stock price for Abeona Therapeutics (NASDAQ: ABEO) is $3.66 last updated September 25, 2023 at 8:00 PM UTC.
Does Abeona Therapeutics (ABEO) pay a dividend?
There is no dividend information for Abeona Therapeutics.
When is Abeona Therapeutics (NASDAQ:ABEO) reporting earnings?
Abeona Therapeutics’s Q3 earnings are confirmed for Monday, November 13, 2023.
Is Abeona Therapeutics (ABEO) going to split?
There is no upcoming split for Abeona Therapeutics.
What sector and industry does Abeona Therapeutics (ABEO) operate in?
Abeona Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Abeona Therapeutics Stock (NASDAQ:ABEO), Quotes and News Summary
Abeona Therapeutics Stock (NASDAQ: ABEO) stock price, news, charts, stock research, profile.
| Open3.900 | Close3.660 |
| Vol / Avg.87.133K / 142.551K | Mkt Cap90.606M |
| Day Range3.650 - 3.900 | 52 Wk Range2.190 - 5.790 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.680 | -0.920 | -0.2400 | ||||
| REV | 3.500M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-24 | Cantor Fitzgerald | Kristen Kluska | Reiterates | OverweightOverweight | Maintains | - | 38.00 |
| 2023-07-13 | Cantor Fitzgerald | Kristen Kluska | Reiterates | OverweightOverweight | Maintains | - | 38.00 |
| 2023-05-24 | Alliance Global Partners | James Molloy | Reiterates | Buy | Maintains | - | 20.00 |
| 2022-11-14 | SVB Leerink | Mani Foroohar | Maintains | Market Perform | Raises | 5.00 | 6.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| ABEO | Abeona Therapeutics | -3.43% | 90.6M |
| IMNM | Immunome | -2.97% | 85.7M |
| CTMX | CytomX Therapeutics | -1.56% | 84.1M |
| BNR | Burning Rock Biotech | 0.99% | 102.7M |
| TTOO | T2 Biosystems | -13.62% | 73.2M |
How do I buy Abeona Therapeutics (ABEO) stock?
You can purchase shares of Abeona Therapeutics (NASDAQ: ABEO) through any online brokerage.
Who are Abeona Therapeutics's (ABEO) competitors?
Other companies in Abeona Therapeutics’s space includes: Immunome (NASDAQ:IMNM), CytomX Therapeutics (NASDAQ:CTMX), Burning Rock Biotech (NASDAQ:BNR), T2 Biosystems (NASDAQ:TTOO) and Armata Pharmaceuticals (AMEX:ARMP).
What is the target price for Abeona Therapeutics (ABEO) stock?
The latest price target for Abeona Therapeutics (NASDAQ: ABEO) was reported by Cantor Fitzgerald on Thursday, August 24, 2023. The analyst firm set a price target for 38.00 expecting ABEO to rise to within 12 months (a possible 938.25% upside). 5 analyst firms have reported ratings in the last year.
Current Stock Price for Abeona Therapeutics (ABEO)?
The stock price for Abeona Therapeutics (NASDAQ: ABEO) is $3.66 last updated September 25, 2023 at 8:00 PM UTC.
Does Abeona Therapeutics (ABEO) pay a dividend?
There is no dividend information for Abeona Therapeutics.
When is Abeona Therapeutics (NASDAQ:ABEO) reporting earnings?
Abeona Therapeutics’s Q3 earnings are confirmed for Monday, November 13, 2023.
Is Abeona Therapeutics (ABEO) going to split?
There is no upcoming split for Abeona Therapeutics.
What sector and industry does Abeona Therapeutics (ABEO) operate in?
Abeona Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Abeona Therapeutics Stock (NASDAQ:ABEO), Quotes and News Summary
Abeona Therapeutics Stock (NASDAQ: ABEO) stock price, news, charts, stock research, profile.
| Open3.900 | Close3.660 |
| Vol / Avg.87.133K / 142.551K | Mkt Cap90.606M |
| Day Range3.650 - 3.900 | 52 Wk Range2.190 - 5.790 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.680 | -0.920 | -0.2400 | ||||
| REV | 3.500M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-24 | Cantor Fitzgerald | Kristen Kluska | Reiterates | OverweightOverweight | Maintains | - | 38.00 |
| 2023-07-13 | Cantor Fitzgerald | Kristen Kluska | Reiterates | OverweightOverweight | Maintains | - | 38.00 |
| 2023-05-24 | Alliance Global Partners | James Molloy | Reiterates | Buy | Maintains | - | 20.00 |
| 2022-11-14 | SVB Leerink | Mani Foroohar | Maintains | Market Perform | Raises | 5.00 | 6.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| ABEO | Abeona Therapeutics | -3.43% | 90.6M |
| IMNM | Immunome | -2.97% | 85.7M |
| CTMX | CytomX Therapeutics | -1.56% | 84.1M |
| BNR | Burning Rock Biotech | 0.99% | 102.7M |
| TTOO | T2 Biosystems | -13.62% | 73.2M |
How do I buy Abeona Therapeutics (ABEO) stock?
You can purchase shares of Abeona Therapeutics (NASDAQ: ABEO) through any online brokerage.
Who are Abeona Therapeutics's (ABEO) competitors?
Other companies in Abeona Therapeutics’s space includes: Immunome (NASDAQ:IMNM), CytomX Therapeutics (NASDAQ:CTMX), Burning Rock Biotech (NASDAQ:BNR), T2 Biosystems (NASDAQ:TTOO) and Armata Pharmaceuticals (AMEX:ARMP).
What is the target price for Abeona Therapeutics (ABEO) stock?
The latest price target for Abeona Therapeutics (NASDAQ: ABEO) was reported by Cantor Fitzgerald on Thursday, August 24, 2023. The analyst firm set a price target for 38.00 expecting ABEO to rise to within 12 months (a possible 938.25% upside). 5 analyst firms have reported ratings in the last year.
Current Stock Price for Abeona Therapeutics (ABEO)?
The stock price for Abeona Therapeutics (NASDAQ: ABEO) is $3.66 last updated September 25, 2023 at 8:00 PM UTC.
Does Abeona Therapeutics (ABEO) pay a dividend?
There is no dividend information for Abeona Therapeutics.
When is Abeona Therapeutics (NASDAQ:ABEO) reporting earnings?
Abeona Therapeutics’s Q3 earnings are confirmed for Monday, November 13, 2023.
Is Abeona Therapeutics (ABEO) going to split?
There is no upcoming split for Abeona Therapeutics.
What sector and industry does Abeona Therapeutics (ABEO) operate in?
Abeona Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Abeona Therapeutics Stock (NASDAQ:ABEO), Quotes and News Summary
Abeona Therapeutics Stock (NASDAQ: ABEO) stock price, news, charts, stock research, profile.
| Open3.900 | Close3.660 |
| Vol / Avg.87.133K / 142.551K | Mkt Cap90.606M |
| Day Range3.650 - 3.900 | 52 Wk Range2.190 - 5.790 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.680 | -0.920 | -0.2400 | ||||
| REV | 3.500M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-24 | Cantor Fitzgerald | Kristen Kluska | Reiterates | OverweightOverweight | Maintains | - | 38.00 |
| 2023-07-13 | Cantor Fitzgerald | Kristen Kluska | Reiterates | OverweightOverweight | Maintains | - | 38.00 |
| 2023-05-24 | Alliance Global Partners | James Molloy | Reiterates | Buy | Maintains | - | 20.00 |
| 2022-11-14 | SVB Leerink | Mani Foroohar | Maintains | Market Perform | Raises | 5.00 | 6.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| ABEO | Abeona Therapeutics | -3.43% | 90.6M |
| IMNM | Immunome | -2.97% | 85.7M |
| CTMX | CytomX Therapeutics | -1.56% | 84.1M |
| BNR | Burning Rock Biotech | 0.99% | 102.7M |
| TTOO | T2 Biosystems | -13.62% | 73.2M |
How do I buy Abeona Therapeutics (ABEO) stock?
You can purchase shares of Abeona Therapeutics (NASDAQ: ABEO) through any online brokerage.
Who are Abeona Therapeutics's (ABEO) competitors?
Other companies in Abeona Therapeutics’s space includes: Immunome (NASDAQ:IMNM), CytomX Therapeutics (NASDAQ:CTMX), Burning Rock Biotech (NASDAQ:BNR), T2 Biosystems (NASDAQ:TTOO) and Armata Pharmaceuticals (AMEX:ARMP).
What is the target price for Abeona Therapeutics (ABEO) stock?
The latest price target for Abeona Therapeutics (NASDAQ: ABEO) was reported by Cantor Fitzgerald on Thursday, August 24, 2023. The analyst firm set a price target for 38.00 expecting ABEO to rise to within 12 months (a possible 938.25% upside). 5 analyst firms have reported ratings in the last year.
Current Stock Price for Abeona Therapeutics (ABEO)?
The stock price for Abeona Therapeutics (NASDAQ: ABEO) is $3.66 last updated September 25, 2023 at 8:00 PM UTC.
Does Abeona Therapeutics (ABEO) pay a dividend?
There is no dividend information for Abeona Therapeutics.
When is Abeona Therapeutics (NASDAQ:ABEO) reporting earnings?
Abeona Therapeutics’s Q3 earnings are confirmed for Monday, November 13, 2023.
Is Abeona Therapeutics (ABEO) going to split?
There is no upcoming split for Abeona Therapeutics.
What sector and industry does Abeona Therapeutics (ABEO) operate in?
Abeona Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Abeona Therapeutics Stock (NASDAQ:ABEO), Quotes and News Summary
Abeona Therapeutics Stock (NASDAQ: ABEO) stock price, news, charts, stock research, profile.
| Open3.900 | Close3.660 |
| Vol / Avg.87.133K / 142.551K | Mkt Cap90.606M |
| Day Range3.650 - 3.900 | 52 Wk Range2.190 - 5.790 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.680 | -0.920 | -0.2400 | ||||
| REV | 3.500M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-24 | Cantor Fitzgerald | Kristen Kluska | Reiterates | OverweightOverweight | Maintains | - | 38.00 |
| 2023-07-13 | Cantor Fitzgerald | Kristen Kluska | Reiterates | OverweightOverweight | Maintains | - | 38.00 |
| 2023-05-24 | Alliance Global Partners | James Molloy | Reiterates | Buy | Maintains | - | 20.00 |
| 2022-11-14 | SVB Leerink | Mani Foroohar | Maintains | Market Perform | Raises | 5.00 | 6.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| ABEO | Abeona Therapeutics | -3.43% | 90.6M |
| IMNM | Immunome | -2.97% | 85.7M |
| CTMX | CytomX Therapeutics | -1.56% | 84.1M |
| BNR | Burning Rock Biotech | 0.99% | 102.7M |
| TTOO | T2 Biosystems | -13.62% | 73.2M |
How do I buy Abeona Therapeutics (ABEO) stock?
You can purchase shares of Abeona Therapeutics (NASDAQ: ABEO) through any online brokerage.
Who are Abeona Therapeutics's (ABEO) competitors?
Other companies in Abeona Therapeutics’s space includes: Immunome (NASDAQ:IMNM), CytomX Therapeutics (NASDAQ:CTMX), Burning Rock Biotech (NASDAQ:BNR), T2 Biosystems (NASDAQ:TTOO) and Armata Pharmaceuticals (AMEX:ARMP).
What is the target price for Abeona Therapeutics (ABEO) stock?
The latest price target for Abeona Therapeutics (NASDAQ: ABEO) was reported by Cantor Fitzgerald on Thursday, August 24, 2023. The analyst firm set a price target for 38.00 expecting ABEO to rise to within 12 months (a possible 938.25% upside). 5 analyst firms have reported ratings in the last year.
Current Stock Price for Abeona Therapeutics (ABEO)?
The stock price for Abeona Therapeutics (NASDAQ: ABEO) is $3.66 last updated September 25, 2023 at 8:00 PM UTC.
Does Abeona Therapeutics (ABEO) pay a dividend?
There is no dividend information for Abeona Therapeutics.
When is Abeona Therapeutics (NASDAQ:ABEO) reporting earnings?
Abeona Therapeutics’s Q3 earnings are confirmed for Monday, November 13, 2023.
Is Abeona Therapeutics (ABEO) going to split?
There is no upcoming split for Abeona Therapeutics.
What sector and industry does Abeona Therapeutics (ABEO) operate in?
Abeona Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Abeona Therapeutics Stock (NASDAQ:ABEO), Quotes and News Summary
Abeona Therapeutics Stock (NASDAQ: ABEO) stock price, news, charts, stock research, profile.
| Open3.900 | Close3.660 |
| Vol / Avg.87.133K / 142.551K | Mkt Cap90.606M |
| Day Range3.650 - 3.900 | 52 Wk Range2.190 - 5.790 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.680 | -0.920 | -0.2400 | ||||
| REV | 3.500M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-24 | Cantor Fitzgerald | Kristen Kluska | Reiterates | OverweightOverweight | Maintains | - | 38.00 |
| 2023-07-13 | Cantor Fitzgerald | Kristen Kluska | Reiterates | OverweightOverweight | Maintains | - | 38.00 |
| 2023-05-24 | Alliance Global Partners | James Molloy | Reiterates | Buy | Maintains | - | 20.00 |
| 2022-11-14 | SVB Leerink | Mani Foroohar | Maintains | Market Perform | Raises | 5.00 | 6.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| ABEO | Abeona Therapeutics | -3.43% | 90.6M |
| IMNM | Immunome | -2.97% | 85.7M |
| CTMX | CytomX Therapeutics | -1.56% | 84.1M |
| BNR | Burning Rock Biotech | 0.99% | 102.7M |
| TTOO | T2 Biosystems | -13.62% | 73.2M |
How do I buy Abeona Therapeutics (ABEO) stock?
You can purchase shares of Abeona Therapeutics (NASDAQ: ABEO) through any online brokerage.
Who are Abeona Therapeutics's (ABEO) competitors?
Other companies in Abeona Therapeutics’s space includes: Immunome (NASDAQ:IMNM), CytomX Therapeutics (NASDAQ:CTMX), Burning Rock Biotech (NASDAQ:BNR), T2 Biosystems (NASDAQ:TTOO) and Armata Pharmaceuticals (AMEX:ARMP).
What is the target price for Abeona Therapeutics (ABEO) stock?
The latest price target for Abeona Therapeutics (NASDAQ: ABEO) was reported by Cantor Fitzgerald on Thursday, August 24, 2023. The analyst firm set a price target for 38.00 expecting ABEO to rise to within 12 months (a possible 938.25% upside). 5 analyst firms have reported ratings in the last year.
Current Stock Price for Abeona Therapeutics (ABEO)?
The stock price for Abeona Therapeutics (NASDAQ: ABEO) is $3.66 last updated September 25, 2023 at 8:00 PM UTC.
Does Abeona Therapeutics (ABEO) pay a dividend?
There is no dividend information for Abeona Therapeutics.
When is Abeona Therapeutics (NASDAQ:ABEO) reporting earnings?
Abeona Therapeutics’s Q3 earnings are confirmed for Monday, November 13, 2023.
Is Abeona Therapeutics (ABEO) going to split?
There is no upcoming split for Abeona Therapeutics.
What sector and industry does Abeona Therapeutics (ABEO) operate in?
Abeona Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Abeona Therapeutics Stock (NASDAQ:ABEO), Quotes and News Summary
Abeona Therapeutics Stock (NASDAQ: ABEO) stock price, news, charts, stock research, profile.
| Open3.900 | Close3.660 |
| Vol / Avg.87.133K / 142.551K | Mkt Cap90.606M |
| Day Range3.650 - 3.900 | 52 Wk Range2.190 - 5.790 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.680 | -0.920 | -0.2400 | ||||
| REV | 3.500M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-24 | Cantor Fitzgerald | Kristen Kluska | Reiterates | OverweightOverweight | Maintains | - | 38.00 |
| 2023-07-13 | Cantor Fitzgerald | Kristen Kluska | Reiterates | OverweightOverweight | Maintains | - | 38.00 |
| 2023-05-24 | Alliance Global Partners | James Molloy | Reiterates | Buy | Maintains | - | 20.00 |
| 2022-11-14 | SVB Leerink | Mani Foroohar | Maintains | Market Perform | Raises | 5.00 | 6.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| ABEO | Abeona Therapeutics | -3.43% | 90.6M |
| IMNM | Immunome | -2.97% | 85.7M |
| CTMX | CytomX Therapeutics | -1.56% | 84.1M |
| BNR | Burning Rock Biotech | 0.99% | 102.7M |
| TTOO | T2 Biosystems | -13.62% | 73.2M |
How do I buy Abeona Therapeutics (ABEO) stock?
You can purchase shares of Abeona Therapeutics (NASDAQ: ABEO) through any online brokerage.
Who are Abeona Therapeutics's (ABEO) competitors?
Other companies in Abeona Therapeutics’s space includes: Immunome (NASDAQ:IMNM), CytomX Therapeutics (NASDAQ:CTMX), Burning Rock Biotech (NASDAQ:BNR), T2 Biosystems (NASDAQ:TTOO) and Armata Pharmaceuticals (AMEX:ARMP).
What is the target price for Abeona Therapeutics (ABEO) stock?
The latest price target for Abeona Therapeutics (NASDAQ: ABEO) was reported by Cantor Fitzgerald on Thursday, August 24, 2023. The analyst firm set a price target for 38.00 expecting ABEO to rise to within 12 months (a possible 938.25% upside). 5 analyst firms have reported ratings in the last year.
Current Stock Price for Abeona Therapeutics (ABEO)?
The stock price for Abeona Therapeutics (NASDAQ: ABEO) is $3.66 last updated September 25, 2023 at 8:00 PM UTC.
Does Abeona Therapeutics (ABEO) pay a dividend?
There is no dividend information for Abeona Therapeutics.
When is Abeona Therapeutics (NASDAQ:ABEO) reporting earnings?
Abeona Therapeutics’s Q3 earnings are confirmed for Monday, November 13, 2023.
Is Abeona Therapeutics (ABEO) going to split?
There is no upcoming split for Abeona Therapeutics.
What sector and industry does Abeona Therapeutics (ABEO) operate in?
Abeona Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.